These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18641326)

  • 1. Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis.
    Liu Y; Li P; Lu J; Xiong W; Oger J; Tetzlaff W; Cynader M
    J Immunol; 2008 Aug; 181(3):1887-97. PubMed ID: 18641326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis.
    Turley DM; Miller SD
    J Immunol; 2007 Feb; 178(4):2212-20. PubMed ID: 17277126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the effects of potentially therapeutic modified peptides on polyclonal T cell populations in a mouse model of multiple sclerosis.
    Sauer EL; Trifilieff E; Greer JM
    J Neuroimmunol; 2017 Jun; 307():18-26. PubMed ID: 28495132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
    Wang Y; Mei Y; Feng D; Xu L
    J Neurosci Res; 2008 Aug; 86(11):2441-9. PubMed ID: 18438925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
    Sun JB; Czerkinsky C; Holmgren J
    J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis.
    Juedes AE; Ruddle NH
    J Immunol; 2001 Apr; 166(8):5168-75. PubMed ID: 11290800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of the surface antigen 3G11 characterizes a distinct population of anergic/regulatory T cells in experimental autoimmune encephalomyelitis.
    Zhang GX; Yu S; Calida D; Zhao Z; Gran B; Kamoun M; Rostami A
    J Immunol; 2006 Mar; 176(6):3366-73. PubMed ID: 16517704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of 15-deoxyspergualin on effector cells in experimental autoimmune diseases of the nervous system in the Lewis rat.
    Jung S; Toyka KV; Hartung HP
    Clin Exp Immunol; 1994 Dec; 98(3):494-502. PubMed ID: 7527745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of autoreactive CD4 T cells in experimental autoimmune encephalomyelitis after primary and secondary challenge using MHC class II tetramers.
    Bischof F; Hofmann M; Schumacher TN; Vyth-Dreese FA; Weissert R; Schild H; Kruisbeek AM; Melms A
    J Immunol; 2004 Mar; 172(5):2878-84. PubMed ID: 14978089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses.
    Nizri E; Irony-Tur-Sinai M; Lory O; Orr-Urtreger A; Lavi E; Brenner T
    J Immunol; 2009 Nov; 183(10):6681-8. PubMed ID: 19846875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium phenylacetate inhibits adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice at multiple steps.
    Dasgupta S; Zhou Y; Jana M; Banik NL; Pahan K
    J Immunol; 2003 Apr; 170(7):3874-82. PubMed ID: 12646656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo.
    Bedoui S; Miyake S; Lin Y; Miyamoto K; Oki S; Kawamura N; Beck-Sickinger A; von Hörsten S; Yamamura T
    J Immunol; 2003 Oct; 171(7):3451-8. PubMed ID: 14500640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of invariant chain processing, antigen-induced proliferative responses, and the development of collagen-induced arthritis and experimental autoimmune encephalomyelitis by a small molecule cysteine protease inhibitor.
    Podolin PL; Bolognese BJ; Carpenter DC; Davis TG; Johanson RA; Fox JH; Long E; Dong X; Marquis RW; Locastro SM; Terfloth GJ; Kurali E; Peterson JJ; Smith BR; McQueney MS; Yamashita DS; Capper-Spudich EA
    J Immunol; 2008 Jun; 180(12):7989-8003. PubMed ID: 18523262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IAs molecules.
    Lamont AG; Sette A; Fujinami R; Colón SM; Miles C; Grey HM
    J Immunol; 1990 Sep; 145(6):1687-93. PubMed ID: 1697306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M).
    Kaushansky N; Eisenstein M; Oved JH; Ben-Nun A
    Int Immunol; 2008 Nov; 20(11):1439-49. PubMed ID: 18801757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.
    McLaughlin PJ; McHugh DP; Magister MJ; Zagon IS
    BMC Immunol; 2015 Apr; 16():24. PubMed ID: 25906771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
    Weissert R; de Graaf KL; Storch MK; Barth S; Linington C; Lassmann H; Olsson T
    J Immunol; 2001 Jun; 166(12):7588-99. PubMed ID: 11390515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite.
    Platten M; Ho PP; Youssef S; Fontoura P; Garren H; Hur EM; Gupta R; Lee LY; Kidd BA; Robinson WH; Sobel RA; Selley ML; Steinman L
    Science; 2005 Nov; 310(5749):850-5. PubMed ID: 16272121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis.
    Chyuan IT; Tsai HF; Wu CS; Sung CC; Hsu PN
    Front Immunol; 2018; 9():15. PubMed ID: 29403497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.